Disseminated Coccidioidomycosis by Wang, Cheng-Yi et al.
LETTERS
Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 11, No. 1, January 2005 177
2.  Bertherat E, Talarmin A, Zeller H.
République Démocratique du Congo: Entre
guerre civile et virus Marburg. Med Trop
(Mars). 1999;59:201–4.
3. Zeller H. Les leçons de l’épidémie à virus
Marburg à Durba, République
Démocratique du Congo (1998–2000).
Med Trop (Mars). 2000;60(2S):23S–6.
4. Bourée P, Bergmann JF. Ebola virus infec-
tion in man: a serological and epidemiolog-
ical survey in the Cameroons. Am J Trop
Med Hyg. 1983;32:1465–6.
5.  Johnson ED, Gonzalez JP, Georges A.
Filovirus activity among selected ethnic
groups inhabiting the tropical forest of
equatorial Africa. Trans R Soc Trop Med
Hyg. 1993;87:536–8.
6.  Gonzalez JP, Nakoune E, Slenczka W,
Vidal P, Morvan JM. Ebola and Marburg
virus antibody prevalence in selected popu-
lations of the Central African Republic.
Microbes Infect. 2000;2:39–44.
Address for correspondence: Matthias Borchert,
London School of Hygiene and Tropical
Medicine, Infectious Diseases Epidemiology
Unit, Keppel Street, London WC1E 7HT,
United Kingdom; fax: 44-20-7299-4720; email:
matthias.borchert@lshtm.ac.uk
Disseminated
Coccidioidomycosis
To the Editor: Coccidioidomy-
cosis, an infection caused by the
dimorphic fungus Coccidioides immi-
tis, is endemic in the southwestern
United States, parts of Mexico, and
Central and South America (1).
Patients with C. immitis infection may
have chronic pneumonia, fungemia,
and extrapulmonary dissemination to
skin, bones, meninges, and other body
sites. The clinical features of coccid-
ioidomycosis may mimic those of
melioidosis, penicilliosis marneffei,
and tuberculosis, which are common-
ly seen in some southeastern Asian
countries, including Taiwan.
A previously healthy, 71-year-old
retired gynecologist from Taiwan, vis-
ited Los Angeles in August 2003 and
traveled to the San Joaquin Valley in
November 2003. He had smoked 1
package of cigarettes daily for 50
years. He noted fever 5 days before
returning to Taiwan on December 1,
2003. He came to a local hospital on
December 4 with a temperature of
39°C and a history of 1 month of night
sweats, productive cough, and weight
loss of 10 kg. Chest radiograph
showed diffuse nodular lung lesions
bilaterally (Figure, panel A). His
leukocyte count was 16.65 x 109/L
(neutrophils 85.6%, lymphocytes
6.2%), and C-reactive protein was
21.5 mg/dL (reference value, <0.8
mg/dL). Empiric antimicrobial drugs
(amoxicillin/clavulanic acid and
ciprofloxacin) and antituberculosis
therapy (isoniazid, rifampin, ethamb-
utol, and pyrazinamide) were admin-
istered. Blood and sputum specimens
were negative for bacteria; HIV anti-
body test results were negative, but
the fever persisted. A follow-up chest
film showed a left pleural effusion.
The pleural effusion aspirate was
exudative with 3.6 x 109/Lleukocytes
(73% neutrophils). Computed tomo-
graphic scan of the patient’s chest
showed collapse of the left lower lung
with central necrosis, bilateral pleural
effusions, and mediastinal lym-
phadenopathy. Pleural biopsy by
video-assisted thoracoscopic surgery
showed no evidence of malignancy,
but heavy lymphoplasmacytic infiltra-
tion and chronic necrotizing granulo-
matous inflammation were found
(Figure, panel C). On December 17,
2003, 30 mg/day prednisolone orally
was prescribed for intermittent fever.
Biopsy material and cultures of blood
samples taken at admission grew an
Figure. A) Chest radiograph shows diffuse nodular lesions in both lungs. B) Chest radi-
ographic scan taken 2 months later shows coalescence of nodular shadows and almost
complete white-out of bilateral lung fields. C) Hematoxylin and eosin staining of the wound
specimen from pleural biopsy site showed spherules of Coccidioides immitis and chronic
necrotizing granulomatous inflammation (400x).LETTERS
unidentified mold, which was also
isolated from the biopsy wound. The
patient was discharged afebrile from
the hospital on January 20, 2004. The
fever recurred, with a disturbance in
consciousness on January 25, 2004.
Computed tomographic scan of the
brain revealed no obvious organic
lesions. He was referred to our hospi-
tal on January 26, 2004.
After the patient was admitted,
fever persisted and respiratory dis-
tress worsened rapidly. He developed
severe headache, seizures, and loss of
consciousness. He was transferred to
the intensive care unit for aggressive
management of acute respiratory dis-
tress syndrome and deterioration of
renal function. Chest radiograph
showed coalescence of nodular shad-
ows and almost complete white-out of
bilateral lung fields (Figure, panel B).
Meropenem, antituberculosis agents,
and intravenous voriconazole, 200 mg
every 12 hours, were administered. 
Both the unidentified mold, which
was sent to our hospital for further
identification, and a mold cultured
from the previous biopsy wound at
our hospital were identified as C.
immitis  by their characteristic gross
and microscopic morphotypes in stan-
dard slide cultures incubated at 28°C
for 10 days. Hematoxylin and eosin
staining of the biopsied tissue showed
many spherules.
Lumbar puncture was performed
on January 30, 2004, and showed an
elevated opening pressure of 380 cm
H2O and a few destructed large
spherules in the cerebrospinal fluid
(CSF). However, cultures of CSF
were negative for bacteria and fungi.
After the diagnosis of disseminated
coccidioidomycosis (pneumonia,
fungemia, and meningitis), voricona-
zole was replaced by intravenous flu-
conazole, 400 mg/day. The patient’s
intensive care course was complicated
by  Pseudomonas  pneumonia and
repeated episodes of upper gastroin-
testinal bleeding. A second lumbar
puncture was conducted on February
13, 2004, and also showed an elevat-
ed opening pressure (290 cm H2O).
Uncontrolled coccidioidomycosis
meningitis was suspected, and
intrathecal amphotericin B treatment
was planned. Refractory shock with
bradycardia developed when an
intrathecal catheter was implanted.
The patient did not respond to therapy
and died on February 16, 2004. The
MIC of fluconzole for the C. immitis
isolate was 48 µg/mL, and the MIC of
amphotericin B was found to be 1
µg/mL for by using the Etest
(ABiodisk, Solna, Sweden) according
to manufacturer’s information.
This case is the first to be reported
of disseminated coccidioidomycosis
with fulminant pneumonia, fungemia,
and meningitis reported from Taiwan
(2). Review of the patient’s travel his-
tory and clinical course indicated that
the  C. immitis was acquired in
California and that the initial manifes-
tations had begun before the patient
returned to Taiwan. Coccidioido-
mycosis is commonly diagnosed in
disease-endemic areas but frequently
overlooked in disease-nonendemic
areas because of a low index of suspi-
cion among physicians. The interval
from onset of symptoms to disease
diagnosis was relatively long (3). Our
patient had chills, productive cough,
weight loss, and night sweats fol-
lowed by fever as the initial manifes-
tations of this infection. These symp-
toms had been most frequently report-
ed in previous coccidioidomycosis
cases (4). Radiographic scans of the
patient initially showed diffuse reticu-
lar lesions, followed by pleural effu-
sion and consolidation. This clinical
course was also fully compatible with
those of previously reported cases (4).
However, the clinical manifestations
of chronic pneumonia with pleural
effusion, the initial partial response to
steroid treatment, and the delay in rec-
ognizing the mold contributed to
delayed diagnosis of this disease. 
The isolate was not susceptible to
fluconazole (MIC 48 µg/mL).
Although the National Committee for
Clinical Laboratory Standards does
not have a standard susceptibility
method and MIC breakpoint of flu-
conazole for defining susceptibility
against  C. immitis. Fluconazole has
been recommended as a drug of
choice for treating meningal coccid-
ioidomycosis, particularly in patients
with underlying renal disease or with
disease-associated renal function
deterioration (4,5). Immunocom-
promise secondary to steroid use, as
well as resistance of the isolate to flu-
conazole, may have contributed to
treatment failure in this patient.
With increasing international trav-
el, physicians should consider those
diseases that are endemic in regions
where their patients have traveled. In
addition to tuberculosis, melioidosis,
and penicilliosis marneffii, coccid-
ioidomycosis should be included in
the differential diagnosis of chronic
pneumonia in Taiwan, considering the
number of residents who travel. Only
then can prompt microbial investiga-
tions be conducted to accurately diag-
nosis and determine the appropriate
antifungal treatment.
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Kytococcus
schroeteri
Endocarditis
To the Editor: Becker et al. recent-
ly reported the probable implication of
Kytococcus schroeteri in a case of
acute prosthetic valve endocarditis, on
the basis of its recovery from blood
cultures drawn at the time of infection
(1). K. schroeteri was only character-
ized on that occasion and is a new
micrococcal species resistant to peni-
cillins (2). Here, we report the isola-
tion of this organism from prosthetic
valve vegetations in a patient who had
undergone aortic valve replacement 3
years earlier. The 73-year-old man was
admitted with fever (38.8°C) and
shortness of breath, which had both
increased gradually over the previous
2 months. He had no recent history of
intravenous drug administration or
catheterization. Laboratory findings
showed a leukocyte count of 12 x
109/L (90% neutrophils) and a raised
C-reactive protein level. Transeso-
phageal echocardiogram revealed sev-
eral small vegetations on the
Carpentier-Edwards aortic bioprosthe-
sis and a voluminous perivalvular
abscess. Four sets of blood cultures
were drawn before antimicrobial ther-
apy was initiated.
Intravenous vancomycin (2 g twice
a day) and gentamicin (240 mg/d)
were started empirically. The prosthet-
ic material was replaced promptly and
the abscess was debrided extensively.
Vegetations from the resected material
showed numerous polymorphonuclear
neutrophils and gram-positive cocci
on microscopic examination. Oral
rifampicin (600 mg twice a day) was
added to the initial regimen.
The postoperative course was
uneventful except for cutaneous intol-
erance to vancomycin, which was
replaced with teicoplanin. The physi-
cal condition of the patient improved
steadily. Gentamicin and rifampicin
were discontinued after 3 weeks.
Eight months after completion of the
6-week treatment, the patient had no
clinical or biologic evidence of infec-
tion, although moderate aortic incom-
petence persisted.
All blood cultures drawn on
admission grew gram-positive cocci
after 72 hours and subcultures on
Trypticase soy agar yielded convex,
muddy-yellow colonies of heteroge-
neous sizes. The vegetations, pus
samples of the abscess, and prosthetic
valve cultures grew the same type of
colonies. All isolates displayed identi-
cal biotype and antimicrobial suscep-
tibility and were considered as a sin-
gle strain. The causative organism
(designated ROG140) was initially
identified as Micrococcus sp. based
on the morphologic features, resist-
ance to nitrofurantoin, and inability to
grow anaerobically. Assignment to the
genus Kytococcus was suggested by
the arginine dihydrolase activity and
resistance to oxacillin, 2 characteris-
tics that are not shared by other micro-
cocci (3).
The definitive K. schroeteri identi-
fication was provided by analysis of
the fatty acid content, which was sim-
ilar to that of the type strain (2), and
sequencing of the 16S rRNA genes.
Figure. (A) Phylogenetic tree showing relationships among 16S rDNA sequences of clini-
cal isolate ROG140 and type strains of members of the former Micrococcus genus.
Nocardia asteroides was included as an out-group organism. The scale bar represents 1%
differences in nucleotide sequences. (B) Sequence alignment of 16S rDNA nucleotides
983-992 and 1003-1014 of Kytococcus sp. type strains (TS) and clinical isolate ROG140.
K. schroeteri molecular signatures are boxed. Nucleotide numbering refers to the
sequence of the 16S rDNA of E. coli.